BioCentury
ARTICLE | Management Tracks

Kramer retires from Emergent

Plus: Zimmermann named CBO at SonoThera and updates from Secretome, Healthcare, Ultima and Koneska

June 27, 2023 11:31 PM UTC

Emergent BioSolutions Inc. (NYSE:EBS) named Haywood Miller as interim CEO following the retirement of Robert Kramer, who was also the company’s president. Miller is managing director at Berkeley Research Group and has advised Emergent for several months; Kramer will remain with the company as an adviser until Aug. 1.

SonoThera Inc., which is developing ultrasound guided non-viral gene therapies, hired Carolyne Zimmermann as CBO. Zimmermann was most recently CBO at 4D Molecular Therapeutics Inc. (NASDAQ:FDMT) and is a 14-year veteran of Novartis AG (SIX:NOVN; NYSE:NVS). ...